Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Common Equity (2020 - 2026)

SkinHealth Systems has reported Common Equity over the past 6 years, most recently at $61.1 million for Q4 2025.

  • Quarterly Common Equity rose 17.86% to $61.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.1 million through Dec 2025, up 17.86% year-over-year, with the annual reading at $61.1 million for FY2025, 17.86% up from the prior year.
  • Common Equity was $61.1 million for Q4 2025 at SkinHealth Systems, down from $65.7 million in the prior quarter.
  • Over five years, Common Equity peaked at $345.4 million in Q2 2022 and troughed at -$142.1 million in Q3 2021.
  • The 5-year median for Common Equity is $67.4 million (2024), against an average of $109.6 million.
  • Year-over-year, Common Equity crashed 605620.03% in 2021 and then skyrocketed 2049.35% in 2022.
  • A 5-year view of Common Equity shows it stood at $298.0 million in 2021, then crashed by 43.95% to $167.1 million in 2022, then plummeted by 64.45% to $59.4 million in 2023, then decreased by 12.77% to $51.8 million in 2024, then rose by 17.86% to $61.1 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Common Equity are $61.1 million (Q4 2025), $65.7 million (Q3 2025), and $74.0 million (Q2 2025).